Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 USD | +6.09% | -5.27% | -5.27% |
02-12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
02-07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.